Activity ID
12155Expires
July 28, 2024Format Type
Journal-basedCME Credit
1Fee
$30CME Provider: JAMA Dermatology
Description of CME Course
A man with stage IV adenocarcinoma of the lung receiving pemetrexed-pembrolizumab presented with redness and swelling of both lower limbs, and sclerotic changes were seen on the biopsy specimen. What is your diagnosis?
Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Orthopaedic Surgery
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
Based on this clinical scenario and the accompanying image, understand how to arrive at a correct diagnosis.
Keywords
Clinical Challenge, Dermatology, Oncology, Targeted and Immune Cancer Therapy, Lung Cancer
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
DOI
10.1001/jamadermatol.2021.2576
